Cyanocabalamin and anticonvulsant-associated congenital defects.
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000818:Animals; D000927:Anticonvulsants / Q000009:adverse effects*; D005260:Female; D006801:Humans; D051379:Mice; D010672:Phenytoin / Q000009:adverse effects; D011247:Pregnancy; D014805:Vitamin B 12 / Q000627:therapeutic use*
D000927:Anticonvulsants; D010672:Phenytoin; D014805:Vitamin B 12